Guoling Xi

Developing an Anion Exchange Chromatography Assay for Determining Empty and Full Capsid Contents in AAV6.2

Chunlei Wang, Sri Hari Raju Mulagapati, Jing Du et al. · Molecular Therapy — Methods & Clinical Development · 2019 · 106 citations · Full text

Life Sciences, Biotechnology, Molecular Biology +13

Congenital Exposure to<i>Plasmodium falciparum</i>Antigens: Prevalence and Antigenic Specificity of In Utero-Produced Antimalarial Immunoglobulin M Antibodies

Guoling Xi, Rose G. F. Leke, Lucy Thuita et al. · Infection and Immunity · 2003 · 50 citations

Veterinary Medicine, Immunology, Infectious Diseases +17

Development and scale‐up of a commercial fed batch refolding process for an anti‐<scp>CD</scp>22 two chain immunotoxin

Thomas Linke, Matthew T. Aspelund, Christopher Thompson et al. · Biotechnology Progress · 2014 · 24 citations · Full text

Life Sciences, Bioengineering, Biotechnology +13

Safety risk management for low molecular weight process‐related impurities in monoclonal antibody therapeutics: Categorization, risk assessment, testing strategy, and process development with leveraging clearance potential

Haibin Luo, Yuling Li, David J. Robbins et al. · Biotechnology Progress · 2020 · 19 citations · Full text

Pharmacy, Biotechnology, Pharmaceutics +16

Identification of compendial nonionic detergents for the replacement of Triton X‐100 in bioprocessing

Alan K. Hunter, Kamiyar Rezvani, Matthew T. Aspelund et al. · Biotechnology Progress · 2022 · 19 citations · Full text

Life Sciences, Biotechnology, Microbiology +12